The Toronto Consensus Statements for the Management of Inflammatory Bowel Disease in Pregnancy
Geoffrey C. Nguyen(Johns Hopkins Medicine), William G. Paterson, John K. Marshall(McMaster University), Carrie Palatnick, Alain Bitton(McGill University Health Centre), Yvette Leung(University of Calgary), Uma Mahadevan(University of California, San Francisco), Grigorios I. Leontiadis(McMaster University), Laura E. Targownik(University of Manitoba), Cynthia Maxwell(Sinai Health System), Brian Bressler(University of British Columbia), J van der Woude(Erasmus University Rotterdam), Jennifer Jones(Dalhousie University), Cynthia H. Seow(University of Calgary), C. Janneke van der Woude(Radboud University Nijmegen), Sharyle Fowler(Massachusetts General Hospital), Frances Tse(McMaster University), Vivian Huang, Joel Ray, Anna Pupco
Cited by 478
Related Papers
Host–microbe interactions have shaped the genetic architecture of inflammatory bowel disease
|Nature|2012|4.8k
A Genome-Wide Association Study Identifies <i>IL23R</i> as an Inflammatory Bowel Disease Gene
|Science|2006|3k
Vedolizumab as Induction and Maintenance Therapy for Crohn's Disease
|New England Journal of Medicine|2013|2.7k
Genome-wide association defines more than 30 distinct susceptibility loci for Crohn's disease
|Nature Genetics|2008|2.6k
ECCO Guidelines on Therapeutics in Crohn's Disease: Medical Treatment
|Journal of Crohn s and Colitis|2019|1.4k